Life In The Old Dog Yet: Growth In Dyslipidemia Market Expected To 2025

 
• By Alexandra Shimmings

Despite the further genericization of statins and ezetimibe, the arrival of expensive new therapies means the dyslipidemia market is still set for growth over the next eight years, say analysts from Datamonitor Healthcare.

Heart
The dyslipidemia market may be old but there's room for growth • Source: Shutterstock

More from Business

More from Scrip